Yayın:
Reduced asymmetric dimethylarginine (ADMA) levels mediate in the protection from metabolic syndrome by smoking

Basit öğe sayfası
dc.contributor.authorOnat, Altan
dc.contributor.authorHergenc, Guelay
dc.date.accessioned2026-06-27T13:09:01Z
dc.date.issued2008
dc.description.urihttps://doi.org/10.1016/j.atherosclerosis.2006.10.040
dc.identifier.doi10.1016/j.atherosclerosis.2006.10.040
dc.identifier.endpage480
dc.identifier.issn0021-9150
dc.identifier.issue1
dc.identifier.pubmed17658534
dc.identifier.startpage479
dc.identifier.urihttps://hdl.handle.net/20.500.14981/50410
dc.identifier.volume196
dc.identifier.wos000253341500063
dc.language.isoeng
dc.publisherELSEVIER IRELAND LTD
dc.relation.ispartofATHEROSCLEROSIS
dc.subjectasymmetric dimethylarginine
dc.subjectcigarette smoking
dc.subjectinsulin resistance
dc.subjectmetabolic syndrome
dc.subjectobesity
dc.subjectRISK
dc.subjectCardiovascular System & Cardiology
dc.titleReduced asymmetric dimethylarginine (ADMA) levels mediate in the protection from metabolic syndrome by smoking
dc.typeLetter
dspace.entity.typePublication
local.import.sourceWOS

Dosyalar

Koleksiyonlar

Yayınlar